China Medical System Holdings Ltd
OTC:CHSYF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Medical System Holdings Ltd
OTC:CHSYF
|
CN |
|
Norsk Hydro ASA
OTC:NHYKF
|
NO |
|
L
|
Loblaw Companies Ltd
F:L8G
|
CA |
|
A
|
AGBA Group Holding Ltd
F:D6D
|
HK |
|
Nuvei Corp
TSX:NVEI
|
CA |
|
Smart Eye AB (publ)
OTC:SMTEF
|
SE |
|
Endeavour Mining PLC
TSX:EDV
|
UK |
|
A
|
Axis Bank Ltd
LSE:AXBA
|
IN |
|
E
|
Edgewell Personal Care Co
F:EGZ
|
US |
|
TOTO Ltd
TSE:5332
|
JP |
|
Profound Medical Corp
TSX:PRN
|
CA |
Wall St Price Targets
CHSYF Price Targets Summary
China Medical System Holdings Ltd
According to Wall Street analysts, the average 1-year price target for CHSYF is 2.22 USD with a low forecast of 1.92 USD and a high forecast of 2.56 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CHSYF's stock price target?
Price Target
2.22
USD
According to Wall Street analysts, the average 1-year price target for CHSYF is 2.22 USD with a low forecast of 1.92 USD and a high forecast of 2.56 USD.
What is the Revenue forecast for China Medical System Holdings Ltd?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 21%.
What is the Operating Income forecast for China Medical System Holdings Ltd?
Projected CAGR
27%
Over the last 14 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 27%.
What is the Net Income forecast for China Medical System Holdings Ltd?
Projected CAGR
27%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 27%.
